Gene Therapy Innovation and Manufacturing Centre
Accelerating the development of gene therapies into life-changing treatments for patients.
The Gene Therapy Innovation and Manufacturing Centre (GTIMC) has been formed as part of the Innovation Hubs for Gene Therapies. The network of Innovation Hubs for Gene Therapies is a new UK initiative designed to advance the clinical development of new genetic treatments through the production of clinical grade vectors, alongside translational support and regulatory advice.
The Sheffield Innovation Hub will dramatically broaden the scope of gene therapy research in the UK. The Sheffield centre brings together partners from the North of England, the Midlands and Wales to advance knowledge on gene therapies so that we can translate scientific discoveries into new and exciting treatments for patients.
University of Sheffield spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases
University of Sheffield spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone.
New research institute to accelerate the search for a cure for MND
The new UK Motor Neuron Disease Research Institute, or UK MND RI, aims to discover new treatments that could ultimately mean MND becomes a curable condition.
Strategic partnership for economic growth in South Yorkshire
GTIMC host venue for signing new memorandum of understanding between South Yorkshire Mayoral Combined Authority (SYMCA) and Aviva Capital Partners Limited.